Doximity (NYSE:DOCS) Stock Rating Upgraded by Truist Financial

Doximity (NYSE:DOCS) was upgraded by stock analysts at Truist Financial from a “hold” rating to a “strong-buy” rating in a note issued to investors on Thursday,Zacks.com reports.

A number of other research analysts have also weighed in on DOCS. Wall Street Zen lowered Doximity from a “buy” rating to a “hold” rating in a research report on Saturday. Barclays raised Doximity to a “strong-buy” rating in a research note on Monday, December 8th. The Goldman Sachs Group raised Doximity from a “strong sell” rating to a “hold” rating in a report on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of Doximity in a report on Wednesday, December 24th. Finally, Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a research note on Thursday. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

Doximity Price Performance

DOCS opened at $43.85 on Thursday. The firm has a market cap of $8.26 billion, a P/E ratio of 34.80, a P/E/G ratio of 2.03 and a beta of 1.39. Doximity has a fifty-two week low of $43.21 and a fifty-two week high of $85.21.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.